Table 3.
Gonadal hormone concentrations in sera and weights of ventral prostate of rats
| Treatment | Testosterone,* ng/ml | Estradiol,† pg/ml | Prostate, mg |
|---|---|---|---|
| Sham-ORX + SO | 2.3 ± 0.6 (n = 15) | 41.4 ± 6.1 (n = 7)‡ | 450 ± 15 (n = 18) |
| ORX + SO | <MCD (n = 5) | 46.6 ± 7.8 (n = 7)‡ | 48 ± 2.5 (n = 20) |
| ORX + TP (1 mg/100 g) | 33.5 ± 0.7 (n = 21) | — | 731 ± 22 (n = 25) |
| ORX + TP (0.5 mg/100 g) | 9.6 ± 1.4 (n = 5) | — | 735 ± 40 (n = 5) |
| ORX + TP (2 mg/100 g) | 49.6 ± 2.6 (n = 4) | — | 862 ± 41 (n = 5) |
| Sham-OVX + SO | — | 36.4 ± 6.4 (n = 10) | — |
| OVX + EB (20 μg/100 g) | — | 750.0 ± 37.4 (n = 7) | — |
n, number of rats; MCD, minimal concentration detectable; ∗ and †, the minimum detectable concentrations were 0.08 ng/ml and 4.7 pg/ml, respectively; ‡, not significantly different (P > 0.05) from each other. Data are mean + SE values.